WATSON 668 (Enalapril 2.5 mg)

Pill imprint WATSON 668 has been identified as Enalapril maleate 2.5 mg.

Enalapril is used in the treatment of high blood pressure; heart failure; diabetic kidney disease; hypertensive emergency; alport syndrome (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Enalapril maleate

Imprint:

WATSON 668

Strength:

2.5 mg

Color:

White

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

00591-0668

Inactive Ingredients:

lactose anhydrous
crospovidone
magnesium stearate
microcrystalline cellulose
potassium bicarbonate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.